<DOC>
	<DOCNO>NCT01930253</DOCNO>
	<brief_summary>Autoimmune cytopenia significant complication observe hematopoietic cell transplant ( HCT ) carry substantial rate morbidity mortality . This entity usually challenge treat , result prolonged hospitalization predispose patient complication either directly due specific cytopenia due immune suppression part therapeutic management . One mediator refractory autoimmune cytopenia antibody produce plasma cell , historically challenge target . The purpose study use proteasome inhibitor call Bortezomib treatment refractory autoimmune cytopenia HCT , monitor clinical response . This pilot study enroll 5 patient 2 year , prospectively . Our hypothesis bortezomib effectively target plasma cell successfully treat refractory autoimmune cytopenia . This relevant study first step establish novel therapeutic modality potentially reduce length hospitalization degree immune suppression refractory autoimmune cytopenia .</brief_summary>
	<brief_title>Use Bortezomib Treat Refractory Autoimmune Cytopenia ( ) Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Leukopenia</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>All patient , undergone allogeneic stem cell transplantation center . Should fail least 2 standard treatment autoimmune cytopenia . Standard treatment include corticosteroid , rituximab , IVIG , plasmapheresis , withdrawal cyclosporine , cyclophosphamide MMF . Definition `` fail '' treatment response cytopenia 2 week continue treatment OR requirement daily GCSF 10 mcgs/kg/day autoimmune neutropenia despite 2 week treatment , transfusion pack red blood cell platelets 3 time weekly 2weeks despite continued treatment OR 5days/week plasmapheresis 2 week inability wean duration . Definition autoimmune hemolytic anemia development anemia , hemoglobin drop &gt; 2 g/dL/48 hour absolute value hemoglobin &lt; 8 g/dL , evidence hemolysis positive direct Coombs test compatible peripheral blood cell morphology , reticulocyte count bilirubin level . Definition autoimmune neutropenia absolute neutrophil count &lt; 500 2 week presence antineutrophil antibody . Definition autoimmune thrombocytopenia Platelet count &lt; 20,000 cells/uL 2 week presence antiplatelet antibody . Ongoing life threaten infection Documented anaphylaxis bortezomib Failed engraftment Relapse primary malignancy â‰¥6/8 match haploidentical transplant</criteria>
	<gender>All</gender>
	<minimum_age>4 Months</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>